TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics April 15, 1977
TCL Archive I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers May 6, 2011
